The United Kingdom’s Tobacco and Vapes Act marks one of the most significant tobacco control reforms in a generation. By introducing a “smoke-free generation” policy and strengthening the regulation of tobacco and vaping products, the legislation establishes an ambitious framework for reducing smoking prevalence and protecting future generations.
But passing legislation is only the beginning.
A recent commentary published in The Lancet Regional Health – Europe argues that while the Act puts the end of smoking within closer reach, it should not be viewed as the endpoint of tobacco control. Writing in the journal, Hazel Cheeseman, Jamie Brown, and colleagues note that the legislation creates “a foundation for further progress” but does not remove the need for continued action to address the more than five million adults in the UK who still smoke.
For GINN, this is an important reminder that successful nicotine policy depends not only on legislation itself, but on how that legislation is implemented, evaluated, and adapted over time.
Implementation Matters as Much as Legislation
The Tobacco and Vapes Act provides governments with new regulatory tools. However, legislation alone cannot reduce smoking prevalence unless it is supported by effective implementation and enforcement.
Cheeseman, Brown, and colleagues argue that the next phase should focus on ensuring that the Act delivers its intended public health outcomes through robust implementation, sustained enforcement, and ongoing evaluation. They also emphasise that tobacco control policies should continue evolving in response to new evidence, emerging products, and changing patterns of nicotine use.
This reflects a broader principle of good regulation: laws must be supported by practical delivery, adequate resources, and continuous review if they are to achieve lasting public health benefits.
Supporting Adults Who Continue to Smoke
While considerable attention has focused on preventing future generations from taking up smoking, millions of adults continue to smoke today.
The authors argue that future priorities should include sustained investment in evidence-based smoking cessation services alongside policies that reduce smoking initiation. Preventing new smokers and helping current smokers quit are complementary public health objectives rather than competing priorities.
For GINN, this distinction is particularly important. Regulatory frameworks should continue to prioritise youth protection while also recognising the needs of adults who currently smoke and may benefit from access to lower-risk alternatives as part of comprehensive tobacco harm reduction strategies.
Addressing Persistent Health Inequalities
Smoking prevalence has declined substantially across the United Kingdom, but progress has not been uniform.
Certain communities continue to experience disproportionately high smoking rates, contributing to persistent health inequalities. Cheeseman, Brown, and colleagues highlight the importance of targeted interventions for populations where smoking remains entrenched, recognising that broad national policies alone may not adequately reach every group.
This reinforces the need for policies that combine national legislation with tailored public health interventions designed to address local needs and disparities.
Monitoring Unintended Consequences
Another key message from the commentary is that implementation should be accompanied by careful evaluation.
Major regulatory reforms can have unintended consequences that may only become apparent over time. Monitoring behavioural responses, market developments, enforcement challenges, and emerging scientific evidence allows policymakers to adjust regulations where necessary and improve their effectiveness.
This is particularly relevant in rapidly evolving nicotine markets, where innovation often moves faster than legislation. A regulatory framework should therefore be capable of adapting to new evidence while maintaining its core public health objectives.
Looking Beyond the Act
The Tobacco and Vapes Act represents an important milestone, but it should not be viewed as the final chapter of tobacco control policy.
As Cheeseman, Brown, and colleagues argue, meaningful progress will depend on sustained implementation, continued investment in cessation services, targeted action for populations with persistently high smoking rates, ongoing evaluation of policy impacts and unintended consequences, and the willingness to adapt regulation as evidence evolves.
For GINN, these priorities are entirely consistent with the principles of evidence-based, risk-proportionate regulation. Strong legislation provides the framework, but achieving better public health outcomes ultimately depends on how effectively those measures are implemented, monitored, and refined over time.
The UK’s experience may therefore offer an important lesson for other jurisdictions. Comprehensive nicotine policy is not a single legislative event—it is an ongoing process of implementation, evaluation, and continuous improvement guided by emerging evidence.
Source: Hazel Cheeseman, Jamie Brown, et al. “The Tobacco and Vapes Act: laying the foundation for a smoke-free future,” The Lancet Regional Health – Europe. https://www.thelancet.com/journals/lanepe/article/PIIS2666-7762(26)00193-6/fulltext
